Read More 10 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights Today, 3:56 PM During Thursday's morning trading, 152 companies set new 52-week lows. ADTX
Read More 6 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Tuesday By Benzinga Insights Today, 3:56 PM During Tuesday's morning trading, 87 companies set new 52-week lows. AAOI
Read More 1 minute read Earnings News Portage Biotech Q2 Net Loss $2.9M By Bill Haddad Today, 3:56 PM Portage Biotech (NASDAQ:PRTG) will report on Q2 2022. PRTG
Read More 1 minute read Movers Trading Ideas Watching Shares Of Valens Semiconductor, Portage Biotech; Traders Circulate TipRanks Report ‘2 ‘Strong Buy’ Stocks Oppenheimer Predicts Will Surge at Least 50%’ Mentioning Stocks By Benzinga Newsdesk Today, 3:56 PM https://www.tipranks.com/news/article/2-strong-buy-stocks-oppenheimer-predicts-will-surge-at-least-50 PRTG
Read More 11 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For September 21, 2021 By Benzinga Insights Today, 3:56 PM Upgrades ATLC
Read More 1 minute read Analyst Ratings Initiation News Price Target Oppenheimer Initiates Coverage On Portage Biotech with Outperform Rating, Announces Price Target of $30 By Benzinga Newsdesk Today, 3:56 PM Oppenheimer analyst Kevin DeGeeter initiates coverage on Portage Biotech (NASDAQ:PRTG) with a Outperform rating and announces Price Target of $30. PRTG
Read More 4 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For September 2, 2021 By Benzinga Insights Today, 3:56 PM ALKS
Read More 1 minute read Analyst Ratings Initiation News Price Target B. Riley Securities Initiates Coverage On Portage Biotech with Buy Rating, Announces Price Target of $40 By Benzinga Newsdesk Today, 3:56 PM B. Riley Securities analyst Justin Walsh initiates coverage on Portage Biotech (NASDAQ:PRTG) with a Buy rating and announces Price Target of $40. PRTG
Read More 7 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For August 19, 2021 By Benzinga Insights Today, 3:56 PM AMAT
Read More 1 minute read Analyst Ratings Initiation News Price Target Cantor Fitzgerald Initiates Coverage On Portage Biotech with Overweight Rating, Announces Price Target of $35 By Benzinga Newsdesk Today, 3:56 PM Cantor Fitzgerald initiates coverage on Portage Biotech (NASDAQ:PRTG) with a Overweight rating and announces Price Target of $35. PRTG